Beyond Compensation: Hyperinsulinemia as an Early Driver of Cardiovascular-Kidney-Metabolic Syndrome.
Hyperinsulinemia represents a clinically relevant and potentially modifiable component of CKM syndrome, with effects extending beyond glucose homeostasis, and recognition of hyperinsulinemia may support earlier risk stratification and mechanism-based interventions.